The insulin delivery devices market has experienced a spike in growth

The global insulin delivery device market was valued at $9,998.3 million in 2015, and it is expected to grow at a CAGR of 6.6% during 2016-2022. Based on type, the insulin pump segment is expected to witness the fastest growth at a CAGR of 7.2% during the forecast period.

The global insulin delivery device market is growing at a significant rate, due to increasing prevalence of diabetes and growing geriatric population. The increasing prevalence of obesity, technological advancement in delivery devices and increasing awareness about diabetic care are also driving the growth of the global insulin delivery device market. However, the factors such as high cost of analogue and hazards and risks associated with drug delivery devices are inhibiting the growth of the global market.

The information and data in the publication “Global Insulin Delivery Device Market Size, Share, Development, Growth and Demand Forecast to 2022” represent the research and analysis of data from various primary and secondary sources. The bottom-top approach has been used to calculate the global market size by type. The market numbers for countries are obtained through top-down approach. P&S Market Research analysts and consultants interacted with authorities from leading companies of the concerned domain, to substantiate every value of data presented in the report. The company bases its primary research on discussions with prominent professionals and analysts in the industry, which is followed by informed and detailed, online, and offline research.

Geographically, North America dominated the global market of insulin delivery device in 2015; whereas the Asia-Pacific market is expected to witness the fastest growth, at a CAGR of 7.2%, during the forecast period.

Some of the key companies operating in the global insulin delivery device market include Novo Nordisk A/S, Medtronic PLC, Abbott Laboratories, Eli Lilly and Company, Insulet Corporation, Sanofi S.A., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Animas Corporation, B. Braun Melsungen AG, and Ypsomed Holdings AG.


Contact Details

Company Name: P&S Market Research
Issued By: Pramod Kumar
Phone: 8887787886
Address: 347 5th Ave. #1402- 210 New York City, NY 10016 United States
City: Ave
State: NY
Zip: 10016
Country: United States
Website: Visit the website

Keywords : insulin delivery devices, Global Insulin Delivery Device Market, Insulin Delivery Device Market Analysis, Insulin Delivery Device Market Demand, Insulin Delivery Device Market Size, Insulin Delivery Device Market Growth,

by Pramod Kumar (few months ago!)

Latest Press Releases

Mods4cars RemoteKEY Comfort Control for Porsche Now in a New Housing

Potato processing Market foreseen to grow exponentially during 2017 - 2025

Automotive Exterior LED Lighting Market Assessment with Trends Analysis and Forecast, 2017-2..

6 Key Takeaways on Skid Steer Loader Market for Forecast Period 2017 – 2026

Grass-fed Protein Market foreseen to grow exponentially during 2017 - 2025

Industrial Packaging Market, by Product Type, By Material Type, and By End-Use Industry

SAP Identity Management Embedded into your Business Processes

Global Smart Watch Market to Grow at Over 16% CAGR and Surpass US$ 30 Bn in Revenues

Dry Rubbing and the Death Grip: Self-pleasuring Problems to Avoid

Facial Rejuvenation Market Latest Trends and Forecast Analysis Upto 2026

Remove this press release ?

Due to extra work required to remove the press-releases we have started charging $1.99 for press release removal.

Your press release will be removed in 24 hours, once the payment has been received.

Search Press Release
e.g. Business, Computer, etc.